Glycotest Overview
- Founded
- 2012

- Status
- Private
- Employees
- 2

- Latest Deal Type
- Series A
- Latest Deal Amount
- $10M

- Investors
- 2
Glycotest General Information
Description
Operator of a liver diagnostics platform intended to commercialize blood tests for life-threatening liver cancers and fibrosis-cirrhosis. The company's platform provides non-invasive blood tests based on proprietary serum biomarkers, biomarker panels and assay technology that exploit novel sugar-based disease signal chemistry, enabling patients with serious liver disease to avail novel clinical laboratory testing services and experience early detection of liver cancer and chronic liver disease.
Contact Information
- 613 Schiller Avenue
- Suite 817
- Merion, PA 19066
- United States
Glycotest Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Corporate (Series A) | 05-Feb-2019 | $10M | 0000 | 0000 | Completed | Clinical Trials - Phase 3 |
3. Buyout/LBO | 31-Dec-2016 | 00.000 | 00.00 | 00.000 | Completed | Clinical Trials - General |
2. Accelerator/Incubator | 05-Jun-2012 | $500K | $1.3M | Completed | Stealth | |
1. Later Stage VC | 25-May-2012 | $801K | $801K | Completed | Stealth |
Glycotest Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Glycotest Comparisons
Industry

0000

0000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialGlycotest Competitors (2)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Fuji | Corporation | Matsuyama, Japan | 0000 | |||
0000 | Corporation | Enid, OK | 00 |
Glycotest Executive Team (4)
Glycotest Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
Ilian Iliev Ph.D | Self | Board Member | 000 0000 |
Jing Yu Ph.D | Fosun Pharma | Board Member | 000 0000 |
Stephen Smith | NetScientific | Board Member | 000 0000 |
Yuejian Zhang | Fosun Pharma | Board Member | 000 0000 |
Glycotest Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialGlycotest Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Fosun Pharma | Corporation | Majority | 000 0000 | 000000 0 | |
NetScientific | Venture Capital | Minority | 000 0000 | 000000 0 |